拱東醫療(605369.SH):以200萬元成立上海拱東
格隆匯2月13日丨拱東醫療(605369.SH)公佈,根據公司戰略規劃,以及未來業務發展的需要,公司以自有資金200萬元人民幣,投資設立上海拱東科技有限公司。
上海拱東已辦理完畢公司設立的相關工商註冊登記手續,並於近日取得了上海市奉賢區市場監督管理局頒發的《營業執照》。
成立上海拱東,系公司管理層基於企業戰略發展規劃以及業務發展需要作出的決定,公司擬藉助上海的區位優勢及人才優勢,提升公司研發綜合實力,尤其是在醫療及生命科學耗材領域的研發能力,為境內外大客户及境外業務拓展提供更多的技術支持,為公司發展提供更多的內生動力和增長點;同時,上海拱東將承擔部分公司在上海區域的銷售及銷售服務工作。未來,公司將根據企業戰略規劃及上海拱東的實際運營情況,追加投資或拓展其職能。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.